Status:
COMPLETED
Salt Sensitivity Hypertension and Lens Opacities
Lead Sponsor:
Kecioren Education and Training Hospital
Conditions:
Salt Hypertension From Excess Dietary Salt
Lens Opacities
Eligibility:
All Genders
40-80 years
Brief Summary
Salt-sensitive hypertension (SSH) accounts for about the half of all Hypertension (HT) cases .In SSH, Na+/K+-ATPase activity is impaired. Impaired Na+/K+-ATPase activity in the lens epithelium results...
Detailed Description
The number of patients with hypertension (HT) worldwide is estimated to reach 1.56 billion by 2025.HT accounts for almost 50% of deaths due to stroke and coronary artery disease. Salt-sensitive hypert...
Eligibility Criteria
Inclusion
- Salt Sensitivity Hypertension patients Non-SSH, salt-resistant HT (SRH) patients Control patients without HT, aged 40-80 years.
Exclusion
- Cataracts Diabetes Mellitus Smoking Hypo/hypercalcemia Hyperparathyroidism Eye trauma Coronary artery disease Cardiac failure Renal failure
- \-
Key Trial Info
Start Date :
March 15 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 7 2017
Estimated Enrollment :
429 Patients enrolled
Trial Details
Trial ID
NCT03385070
Start Date
March 15 2017
End Date
December 7 2017
Last Update
December 29 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Health Sciences.Keçiören Education and Training Hospital
Ankara, Turkey (Türkiye), 06400